Stay updated with breaking news from Cardea bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wilmington, DE (PRWEB) December 01, 2021 -- Each year The Scientist seeks to highlight the latest and greatest tools, technologies, and techniques to hit the
Nature, a world-leading scientific journal, today announced Dr. Kiana Aran, associate professor at Keck Graduate Institute, and Chief Scientific Officer at Cardea Bio, Inc., won the 2021 Nature Research
LONDON SAN DIEGO-(BUSINESS WIRE)- Nature , a world - leading Scientific journal, today announced Dr. Kiana Aran , associate professor at Keck Graduate ...
Claremont, CA (PRWEB) October 28, 2021 -- Keck Graduate Institute (KGI) Associate Professor Dr. Kiana Aran and Co-founder and Chief Scientific Officer of
Global Market for Advanced Materials in Biosensors: Graphene to Play a Vital Role in the Development of Biosensor Technology prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Market for Advanced Materials in Biosensors: Graphene to Play a Vital Role in the Development of Biosensor Technology prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Emerging Opportunities of Advanced Materials in Biosensors: Advancements in Nanotechnology-based Materials Encouraging Biosensor Development in Remote Health Monitoring Applications – ResearchAndMarkets.com financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
IDTechEx: Has the Funding for Graphene Dried Up prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.
January Therapeutics today announced the appointment of Dr. Paul Grint to the Board of Directors Share Article Dr. Paul Grint is bringing his experience as CMO, CEO (Private & Public Companies), Chairman of the Board, and Board Member to help January's Board SAN DIEGO (PRWEB) May 05, 2021 Dr. Grint has served as the Executive Chairman of the Board of Directors of Cardea Bio since April 2020. He also has served as a member of the Board of Directors and as a member of the compensation committee of Amplyx Pharmaceuticals, Inhibikase Therapeutics and Synedgen. From 2017 to 2019, Dr. Grint served as Chief Executive Officer of AmpliPhi Biosciences and as a member of AmpliPhi Bioscience’s Board of Directors from 2015 to 2019, additionally from 2014 to 2017 Dr. Grint served as Chief Executive Officer of Regulus Therapeutics, Inc., both publicly traded clinical stage biopharmaceutical companies.